These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21599011)

  • 1. Viral quantitative capillary electrophoresis for counting intact viruses.
    Mironov GG; Chechik AV; Ozer R; Bell JC; Berezovski MV
    Anal Chem; 2011 Jul; 83(13):5431-5. PubMed ID: 21599011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral quantitative capillary electrophoresis for counting and quality control of RNA viruses.
    Azizi A; Mironov GG; Muharemagic D; Wehbe M; Bell JC; Berezovski MV
    Anal Chem; 2012 Nov; 84(21):9585-91. PubMed ID: 23046075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring viral DNA release with capillary electrophoresis.
    Krylova SM; Rozenberg D; Coulton JW; Krylov SN
    Analyst; 2004 Dec; 129(12):1234-7. PubMed ID: 15565224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus separation from cell extracts using capillary electrophoresis: potential use in vaccine production and control?
    Oita I; Halewyck H; Pieters S; Thys B; Heyden YV; Rombaut B
    J Virol Methods; 2012 Oct; 185(1):7-17. PubMed ID: 22659068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new quantitative method for circulating DNA level in human serum by capillary zone electrophoresis with laser-induced fluorescence detection.
    Zhang P; Ren J; Shen Z
    Electrophoresis; 2004 Jun; 25(12):1823-8. PubMed ID: 15213980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus analysis using electromigration techniques.
    Kremser L; Blaas D; Kenndler E
    Electrophoresis; 2009 Jan; 30(1):133-40. PubMed ID: 19101933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of fluorescent dye to genomic RNA inside intact human rhinovirus after viral capsid penetration investigated by capillary electrophoresis.
    Kremser L; Okun VM; Nicodemou A; Blaas D; Kenndler E
    Anal Chem; 2004 Feb; 76(4):882-7. PubMed ID: 14961716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
    Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
    J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of vaccinia virus in glioma model.
    Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
    Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of rotavirus double-layered particles and triple-layered particles by capillary zone electrophoresis.
    Mathis PK; Ciarlet M; Campbell KM; Wang S; Owen KE; Ranheim TS
    J Virol Methods; 2010 Oct; 169(1):13-21. PubMed ID: 20599561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells.
    Hsiao JC; Chung CS; Drillien R; Chang W
    Virology; 2004 Nov; 329(1):199-212. PubMed ID: 15476887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of intracellular and extracellular particles of the vaccinia virus].
    Vanderplasschen A
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):381-7. PubMed ID: 10992888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size analysis of residual host cell DNA in cell culture-produced vaccines by capillary gel electrophoresis.
    Shen X; Chen X; Tabor DE; Liu Y; Albarghouthi M; Zhang YF; Galinski MS
    Biologicals; 2013 May; 41(3):201-8. PubMed ID: 23313102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-particle characterization of oncolytic vaccinia virus by flow virometry.
    Tang VA; Renner TM; Varette O; Le Boeuf F; Wang J; Diallo JS; Bell JC; Langlois MA
    Vaccine; 2016 Sep; 34(42):5082-5089. PubMed ID: 27614781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons between capillary zone electrophoresis and real-time PCR for quantification of circulating DNA levels in human sera.
    Sang F; Ren J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):122-8. PubMed ID: 16725393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Coupar BE; Andrew ME; Both GW; Boyle DB
    Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses.
    Singh RK; Balamurugan V; Hosamani M; Kallesh DJ; Bhanuprakash V
    J Virol Methods; 2008 Dec; 154(1-2):146-53. PubMed ID: 18790707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
    Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
    J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.